Mylan Pharmaceuticals Inc. recalls
Every recall we track for Mylan Pharmaceuticals Inc. — 84 in all, from 2012–2026 — plus the complaints and injury reports the public filed about them. 9 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Mylan Pharmaceuticals Inc. peaked in 2018 (23); 56 since 2017. 11% rated “stop using now”.
All FDA recall records for Mylan Pharmaceuticals Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 3 | 7 | 10 |
| 2018 | 5 | 2 | 6 | 10 | 23 |
| 2019 | 0 | 1 | 2 | 3 | 6 |
| 2020 | 1 | 2 | 1 | 1 | 5 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 4 | 2 | 6 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 1 | 0 | 1 |
| 2026 (to date) | 0 | 1 | 3 | 1 | 5 |
Mylan Pharmaceuticals Inc. recalls before 2017
Recalls on record by year.
Most common reasons for Mylan Pharmaceuticals Inc. recalls
What to do if you have a recalled Mylan Pharmaceuticals Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Mylan Pharmaceuticals Inc. recalls
55 shown- Lower riskDrug
Mylan Pharmaceuticals Inc recalls Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,
Mylan recalls 500mg Mycophenolate Mofetil injections due to failed dissolution specifications. Affected lots manufactured in India with specific NDC numbers and expiration dates. Patients should contact Mylan for details.
MylanAug 26, 2026 - Lower riskDrug
Mylan Pharmaceuticals Inc recalls Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc.,
Mylan recalls 10mg Prasugrel tablets that failed 18-month stability testing. These tablets may not be safe for long-term use. Consumers should contact Mylan for details.
MylanAug 17, 2026 - Lower riskDrug
Mylan Pharmaceuticals Inc recalls Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc.,
Mylan recalls 333mg Acamprosate Calcium tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact Mylan for details.
MylanJul 24, 2026 - UnratedDrug
MYLAN PHARMACEUTICALS INC recalls Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for:
Mylan recalls 500mg Mycophenolate Mofetil injections due to potential precipitate formation. Affected lots manufactured in India with specific NDC numbers and expiration dates.
MylanJul 2, 2026 - Use cautionDrug
MYLAN PHARMACEUTICALS INC recalls Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for:
Mylan Pharmaceuticals is recalling specific lots of Amnesteem (Isotretinoin) 40 mg capsules because they failed dissolution specifications.
Mylan PharmaceuticalsFeb 24, 2026 - Lower riskDrug
MYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV
Mylan recalls 5mg Prasugrel tablets with low dissolution risk. Check NDC 0378-5185-93 and lots 3211073-3211075 for affected products.
MylanFeb 25, 2025 - Lower riskDrug
Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71),
Mylan recalls insulin pens with missing labels to prevent medication errors. Affected pens have specific NDC numbers and were sold with expiration dates through August 2023.
MylanJul 5, 2022 - Lower riskDrug
Mylan Pharmaceuticals Inc recalls Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside
Mylan recalls insulin glargine vials with missing labels to prevent medication errors. This insulin product (100 units/mL, 10mL vial) was manufactured with a missing label that could lead to incorrect dosing.
MylanApr 12, 2022 - UnratedDrug
Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC,
Mylan recalls Rifampin injections due to impurities found in stability testing. Affected lots expire Dec 2022 to Apr 2023. Stop using if you have these specific lots.
MylanApr 7, 2022 - Lower riskDrug
Mylan Pharmaceuticals Inc recalls Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.,
Mylan recalls Travoprost Ophthalmic Solution 0.004% 2.5mL bottles due to subpotent drug levels and impurities. This may affect prescription eye drops for glaucoma treatment.
MylanApr 1, 2022 - UnratedDrug
Mylan Pharmaceuticals Inc recalls Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx
Mylan recalls Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) 10g aerosol containers due to cGMP deficiencies. Rx only products distributed by Meda Pharmaceuticals.
MylanJan 21, 2022 - Lower riskDrug
Mylan Pharmaceuticals Inc recalls Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3
Mylan recalls Semglee (insulin glargine) prefilled pens with missing labels. Check your product's NDC 49502-0196-71 or 49502-0196-75 for affected units. No immediate action needed but label verification is critical for safe use.
MylanJan 5, 2022 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Candesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDC
Mylan Pharmaceuticals recalls specific lots of Candesartan Cilexetil and Hydrochlorothiazide tablets due to out-of-specification organic impurities.
Mylan PharmaceuticalsOct 2, 2020 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC
Mylan recalls 5mg Tacrol: Risk of foreign 1mg capsules in 5mg bottles. Stop using if you have the specific lot numbers.
MylanMar 23, 2020 - Stop using nowDrug
Mylan Pharmaceuticals Inc. recalls Sotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA.
Mylan recalls 80mg Sotalol tablets with metal particles. Stop using if you have these specific bottles.
MylanMar 9, 2020 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Nizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.
Mylan recalls 150mg Nizatidine capsules due to trace NDMA impurity. This potential carcinogen may pose health risks. Consumers should check product details and follow official guidance.
MylanJan 7, 2020 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Alprazolam Tablets, USP 0.5 mg, 500-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV
Mylan recalls 500-count Alprazolam tablets (0.5mg) manufactured in Australia with foreign substance. Affected lots expire September 2020. Consumers should contact Mylan for details.
MylanOct 23, 2019 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505
Mylan recalls 5mg Prasugrel tablets with low dissolution results. This may affect drug effectiveness. Check NDC 0378-5185-93 and lot 3089793 for affected products.
MylanOct 18, 2019 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Gatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc., Morgantown, WV
Mylan recalls Gatifloxacin Ophthalmic Solution 0.5% due to failed impurities. This medication may contain an unknown impurity that could pose risks. Consumers should contact Mylan for details.
MylanSep 6, 2019 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b)
Mylan recalls 100-count and 500-count Diltiazem HCl 180mg capsules due to impurities found in stability testing. This may affect safety. Contact Mylan for details.
MylanFeb 13, 2019 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered
Mylan recalls Dymista nasal spray due to potential broken glass in bottle necks. Stop using if you have this product.
MylanFeb 1, 2019 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC
Mylan recalls 180mg fexofenadine tablets with slightly elevated impurities from stability testing. Consumers should check NDC codes and expiration dates for affected lots.
MylanJan 18, 2019 - Lower riskFood
Mylan Pharmaceuticals Inc. recalls DrNatura Toxinout Kit Broad Spectrum Detoxification Program
Mylan recalls DrNatura Toxinout Kit Broad Spectrum Detoxification Program due to undeclared soy allergen. Consumers should check lot numbers and contact Mylan for details.
MylanDec 10, 2018 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Amlodipine and Valsartan Tablets, USP,10 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan
Mylan recalls 30-count prescription Amlodipine and Valsartan tablets made in India with a confirmed impurity that could pose health risks. Consumers should contact Mylan for details.
MylanNov 20, 2018 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing
Mylan Pharmaceuticals recalls 3 extended-cycle birth control pill packs with incorrect labeling on blister packs. This affects prescription-only pills sold in India with specific NDC and lot numbers.
MylanAug 27, 2018 - Stop using nowDrug
Mylan Pharmaceuticals Inc. recalls Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown,
Mylan recalls 120mg Diltiazem capsules due to impurities found in stability testing. This may cause serious injury. Stop using immediately and contact Mylan for details.
MylanAug 7, 2018 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23
Mylan recalls Dymista nasal spray due to potential glass fragments in bottles. This could cause injury if the glass breaks during use. Affected units were manufactured in India with specific lot numbers and expiration dates.
MylanJul 25, 2018 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc.
Mylan recalls 100-count Triamterene-Hydrochlorothiazide tablets (37.5mg/25mg) due to subpotent drug levels. Rx-only product with specific lot number and expiration date.
MylanJul 9, 2018 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan
Mylan recalls 100-count Maxzide-25 tablets (37.5mg/25mg) due to slightly elevated drug levels in routine testing. This may cause higher than intended drug effects.
MylanJun 7, 2018 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 15 mg, Rx Only, 48-count bottle, NDC 00378-4715-22
Mylan recalls 15mg PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets due to CGMP deviations. Affected lots expire by August 2018. Consumers should contact Mylan for details.
MylanApr 30, 2018 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Mylan Pharmaceuticals recalls 11,650 bottles of Loxapine Capsules USP 50 mg due to Current Good Manufacturing Practice deviations. Check your lot numbers.
Mylan PharmaceuticalsApr 24, 2018 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV
Mylan recalls 100-count Amlodipine and Benazapril capsules due to cleaning process deviations in manufacturing. Products with specific NDC and lot numbers are affected.
MylanApr 24, 2018 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharmaceuticals Inc.
Mylan Pharmaceuticals is recalling specific lots of 300 mg extended-release bupropion tablets due to failed impurity specifications from stability testing.
MylanNov 3, 2017 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Montelukast Sodium Oral Granules, 4 mg pouch, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-6040-93
Mylan recalls Montelukast Sodium Oral Granules (4 mg pouch) due to impurity issues. This prescription medication may contain unsafe levels of sulfoxide and total impurities.
MylanMay 9, 2017 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Atorvastatin Calcium Tablets, 10 mg*, packaged in a) 90-count bottles (NDC 0378-3950-77); b) 90-count bottles (NDC
Mylan recalls 10mg Atorvastatin Calcium Tablets with potential microbial contamination. Affected lots have specific NDC numbers and expiration dates. Consumers should check their product details and contact Mylan for guidance.
MylanMar 20, 2017 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tablets (NDC
Mylan recalls 1 mg/0.02 mg norethindrone tablets due to chemical contamination from paint thinner vapors during manufacturing. This may pose health risks. Consumers should contact Mylan for details.
MylanJan 30, 2017 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV ---
Mylan recalls 5mg Glipizide Extended-Release Tablets due to possible presence of 10mg tablets in some bottles. This could lead to incorrect dosing if taken without knowing.
MylanJan 19, 2017 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals
Mylan recalls 45mg mirtazapine tablets (30, 100, 500 count) due to possible glipizide tablets contaminating the bottles. Affected products were sold with specific NDC numbers and expiration dates.
Mylan PharmaceuticalsJan 19, 2017 - Lower riskDrug
Mylan Pharmaceuticals Inc. recalls Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC
Mylan recalls 120mg Diltiazem HCl Extended-release Capsules due to failed impurities tests. Products with NDC 0378-5220-01 or 0378-5220-05 may have harmful levels of a known compound.
MylanNov 3, 2016 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Manufactured and Distributed by: Mylan
Mylan recalls 1 mg Alprazolam Extended-release tablets due to failed dissolution specifications. Check your lot number and expiration date for details.
MylanJun 22, 2016 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV
Mylan recalls 1.5 mg Paliperidone extended-release tablets due to failed dissolution specifications. Check lot numbers and NDC for details.
MylanFeb 12, 2016 - Use cautionDrug
Mylan Pharmaceuticals Inc recalls Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC
Mylan Pharmaceuticals recalls one lot of 500 mg Capecitabine tablets because they failed dissolution specifications. Check your bottle's lot number.
Mylan PharmaceuticalsJun 30, 2015 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original
Mylan recalls Fexofenadine HCl 60mg tablets due to failed impurity specifications. Check lot #3047303, exp 04/2015.
MylanMar 11, 2015 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by Mylan Pharmaceuticals, Inc.
Mylan recalls 15,966 bottles of Metoprolol Succinate 50mg tablets due to the presence of a foreign tablet. Check your lot number and expiration date.
Mylan PharmaceuticalsJul 3, 2014 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Tolterodine Tartrate Tablets, 1 mg, 60 Tablet Bottles, Rx only. Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC:
Mylan Pharmaceuticals is recalling specific lots of 1 mg Tolterodine Tartrate tablets due to failed impurity specifications. Check your bottle's lot number.
Mylan PharmaceuticalsJun 20, 2014 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc.,
Mylan recalls 2,658 bottles of Diltiazem HCl 120 mg capsules due to failed impurity specifications. Check your lot number and expiration date.
Mylan PharmaceuticalsJun 19, 2014 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distributed by Mylan Pharmaceuticals Inc.
Mylan recalls 138,970 bottles of Levothyroxine Sodium Tablets 200 mcg due to subpotent assay results. Check your lot numbers for details.
Mylan PharmaceuticalsJan 14, 2014 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Ciprofloxacin Tablets, USP, 500 mg,100-count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A,
Mylan recalls 941,270 bottles of Ciprofloxacin Tablets USP 500 mg due to Good Manufacturing Practice deviations. Check your lot numbers.
MylanSep 13, 2013 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan
Mylan Pharmaceuticals recalled unopened bottles of Ropinirole USP 3 mg tablets mislabeled as 4 mg. Check your NDC and lot number for details.
MylanApr 22, 2013 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Lisinopril Tablets, USP 10 mg, Rx only, 1000 count bottles, Manufactured for: Mylan Pharmaceuticals Inc ,Morgantown, WV
Mylan recalls 2,405 bottles of Lisinopril 10mg tablets due to incorrect imprint codes. Check your lot number and expiration date for details.
Mylan PharmaceuticalsFeb 26, 2013 - Stop using nowDrug
Mylan Pharmaceuticals Inc. recalls Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan
Mylan recalls 1,894 bottles of Lansoprazole 30 mg capsules due to potential contamination with topiramate tablets. Check your lot number.
MylanJan 30, 2013 - UnratedDrug
Mylan Pharmaceuticals Inc. recalls Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
Mylan recalls specific lots of Carvedilol Tablets, USP, 12.5 mg due to failed specifications for tablet weight and thickness.
Mylan PharmaceuticalsJan 16, 2013 - Stop using nowDrug
Mylan Pharmaceuticals Inc. recalls Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD,
Mylan Pharmaceuticals recalls 24,331 bottles of Doxazosin Tablets USP 2 mg due to cross-contamination with acetaminophen and codeine. Check your lot number.
Mylan PharmaceuticalsAug 7, 2012 - Stop using nowDrug
Mylan Pharmaceuticals Inc. recalls Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown,
Mylan recalls Levetiracetam Tablets USP 500 mg due to potential adulteration with foreign tablets. Check your lot number and expiration date for details.
Mylan PharmaceuticalsJul 27, 2012 - Use cautionDrug
Mylan Pharmaceuticals Inc. recalls Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC
Mylan Pharmaceuticals is recalling specific lots of Famotidine Tablets USP, 20 mg due to out-of-specification impurities found during stability testing.
Mylan PharmaceuticalsJun 28, 2012
Mylan Pharmaceuticals Inc. recall questions
How many recalls has Mylan Pharmaceuticals Inc. had?
84 recalls from Mylan Pharmaceuticals Inc. are on record with U.S. safety agencies, from 2012–2026 (82 drug, 2 food).
What is the most recent Mylan Pharmaceuticals Inc. recall?
Mylan Pharmaceuticals Inc recalls Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,, dated Aug 26, 2026. Every Mylan Pharmaceuticals Inc. recall is listed on this page, newest first.
Why are Mylan Pharmaceuticals Inc. products recalled?
The most common reasons on record: CGMP Deviations (5); Failed Dissolution Specifications (4).
What should I do if I have a recalled Mylan Pharmaceuticals Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Mylan Pharmaceuticals Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.